Companion Animal Welfare

Dog Mast Cell Tumour Welfare Management

Mast cell tumours are common canine skin tumours with variable malignancy requiring appropriate staging and treatment.

Key Facts

Mast cell tumours account for 16-21% of all canine skin tumours
Histological grading predicts biological behaviour but correlation is imperfect
Surgical excision with adequate margins is curative for low-grade tumours
Tyrosine kinase inhibitors including masitinib provide systemic treatment options
Breeds including Boxers, Retrievers and Bulldogs have higher prevalence

Welfare Considerations

Mast cell tumour welfare depends on accurate staging and appropriate treatment. Low-grade tumours treated adequately by surgery carry excellent prognosis. High-grade tumours require systemic treatment and palliative care. Owner education on monitoring for new tumours improves long-term welfare outcomes.

What You Can Do

Seek veterinary assessment for any new skin lump in your dog promptly
Request histological grading and staging for confirmed mast cell tumours
Monitor regularly for new skin masses in breeds with high mast cell tumour prevalence